Varenicline → Abnormal dreams — Audit-grade candidate (scan)

← All findings ⬇ Download signed audit packet

Ledger entry · candidate

Varenicline → Abnormal dreams — Audit-grade candidate (scan)

Drug: varenicline · AE: Abnormal dreams

Discovered via single-drug scan of varenicline. PRR = 56.87 (95% CI 54.36–59.51), n = 1876 cases. Pre-reg locked at submission time.

Disproportionality

PRR: 56.874543136421586 (95% CI 54.36–59.51)
Yates χ²: 95957.87140188785
Cases (case-drug + AE): n = 1876
Verdict: PASSES_ALL_GATES — PRR=56.87 (95% CI 54.36–59.51), n=1876 cases; flagged for clinical expert review, NOT for external escalation without manual verification

Top reactions in cohort

MedDRA PT	n
No reactions surfaced in cohort.

Source: openFDA FAERS, Caliper Engine v0. Pre-registration sha1 locked at submission time; ledger entry signed with platform Ed25519 key.

Independent Verification & Validation

Every finding includes an in-engine adversary review at no cost. For findings you plan to cite in a regulatory submission, scientific publication, or board-grade decision, we offer an additional layer of independent, audit-grade verification — reviewed by an externally-trained system that has never seen your data, your training corpus, or our hardware, and cryptographically signed.

Reference: 3fae907ac1e7ec2ebe813559b3cd4a4f2df63cdf